Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,779,495
-
Share change
-
-626,379
-
Total reported value
-
$16,373,000
-
Price per share
-
$4.38
-
Number of holders
-
25
-
Value change
-
-$2,899,825
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of TRACON PHARMACEUTICALS INC - COM (TCON) as of Q2 2016
As of 30 Jun 2016,
TRACON PHARMACEUTICALS INC - COM (TCON) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,779,495 shares.
The largest 10 holders included
NEA Management Company, LLC, EVENTIDE ASSET MANAGEMENT, LLC, QVT Financial LP, WALL STREET ASSOCIATES, VANGUARD GROUP INC, Candriam Luxembourg S.C.A., Visium Asset Management, LP, DEERFIELD MANAGEMENT CO, ClariVest Asset Management LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.